News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
15,122 Results
Type
Article (684)
Company Profile (1)
Press Release (14437)
Section
Business (3564)
Career Advice (19)
Deals (534)
Drug Delivery (2)
Drug Development (4957)
Employer Resources (2)
FDA (402)
Job Trends (332)
News (9103)
Policy (669)
Tag
Academia (49)
Adcomms (1)
Allergies (2)
Alliances (942)
ALS (5)
Alzheimer's disease (139)
Antibody-drug conjugate (ADC) (3)
Approvals (407)
Artificial intelligence (5)
Autoimmune disease (1)
Automation (1)
Bankruptcy (5)
Best Places to Work (333)
Biosimilars (11)
Biotechnology (1)
Bladder cancer (6)
Breast cancer (4)
Cancer (60)
Cardiovascular disease (9)
Career advice (17)
CAR-T (2)
Cell therapy (11)
Clinical research (4443)
Collaboration (31)
Complete response letters (1)
COVID-19 (98)
CRISPR (3)
C-suite (4)
Cystic fibrosis (2)
Data (136)
Denatured (2)
Depression (2)
Diabetes (17)
Diagnostics (118)
Digital health (1)
Diversity (2)
Drug discovery (8)
Drug shortages (1)
Duchenne muscular dystrophy (1)
Earnings (2025)
Editorial (2)
Employer branding (1)
Employer resources (2)
Events (1530)
Executive appointments (8)
FDA (456)
Funding (20)
Gene editing (4)
Generative AI (1)
Gene therapy (9)
GLP-1 (28)
Government (84)
Guidances (3)
Healthcare (366)
Huntington's disease (3)
IgA nephropathy (5)
Immunology and inflammation (2)
Indications (1)
Infectious disease (101)
Inflammatory bowel disease (16)
Influenza (1)
Intellectual property (1)
Interviews (3)
IPO (339)
Job creations (25)
Job search strategy (14)
Layoffs (7)
Leadership (1)
Legal (56)
Liver cancer (3)
Lung cancer (10)
Lymphoma (7)
Management (1)
Manufacturing (8)
MASH (2)
Medical device (148)
Medtech (148)
Mergers & acquisitions (198)
Metabolic disorders (39)
Multiple sclerosis (11)
Neurodegenerative disease (2)
Neuroscience (174)
NextGen: Class of 2025 (82)
Non-profit (37)
Obesity (22)
Opinion (5)
Ovarian cancer (4)
Pain (6)
Pancreatic cancer (4)
Parkinson's disease (10)
Partnered (1)
Patents (7)
Patient recruitment (7)
Peanut (1)
People (560)
Phase I (827)
Phase II (1974)
Phase III (1883)
Pipeline (94)
Policy (1)
Postmarket research (144)
Preclinical (229)
Press Release (4)
Prostate cancer (1)
Radiopharmaceuticals (4)
Rare diseases (7)
Real estate (63)
Regulatory (592)
Research institute (87)
Resumes & cover letters (3)
RSV (1)
Schizophrenia (6)
Series A (3)
Series B (2)
Sickle cell disease (2)
Spinal muscular atrophy (3)
Startups (73)
Supply chain (1)
The Weekly (1)
Vaccines (11)
Weight loss (14)
Women's health (1)
Worklife (1)
Date
Today (7)
Last 7 days (30)
Last 30 days (82)
Last 365 days (1095)
2025 (370)
2024 (1150)
2023 (1311)
2022 (1540)
2021 (1601)
2020 (1475)
2019 (1069)
2018 (718)
2017 (826)
2016 (677)
2015 (828)
2014 (542)
2013 (418)
2012 (385)
2011 (479)
2010 (342)
Location
Africa (14)
Alabama (2)
Arizona (4)
Asia (1247)
Australia (237)
California (206)
Canada (43)
China (28)
Colorado (5)
Connecticut (6)
Delaware (10)
Europe (3592)
Florida (17)
Georgia (10)
Illinois (22)
India (2)
Indiana (15)
Japan (8)
Kansas (8)
Maryland (23)
Massachusetts (125)
Michigan (5)
Minnesota (5)
Nevada (11)
New Jersey (72)
New Mexico (1)
New York (72)
North Carolina (21)
Northern California (95)
Ohio (4)
Oklahoma (2)
Pennsylvania (45)
Rhode Island (1)
South America (7)
Southern California (84)
Texas (15)
United States (708)
Utah (6)
Virginia (1)
Washington State (22)
Wisconsin (3)
15,122 Results for "parallel".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Parallel Bio Appoints Deep Tech Innovator Ari Gesher as Head of Technology
Parallel Bio, a biotech company using the immune system to cure disease, today announced that Ari Gesher has joined as the first head of technology.
June 26, 2024
·
3 min read
Parallel Bio Launches Clinical Trial in a Dish to Speed Drug Discovery
Parallel Bio, a biotech company using the immune system to cure disease, today announced the release of its Clinical Trial in a Dish for studying the efficacy and safety
May 16, 2024
·
4 min read
Legal
Novo Enters the Ring in Legal Fight Against GLP-1 Compounders as Lilly Notches Victory
Novo Nordisk is intervening in the lawsuit filed by a drug compounders trade group against the FDA over the agency’s decision to declare the Wegovy shortage over. Eli Lilly did the same in a parallel case over Zepbound’s removal from the FDA shortage list and this week a judge denied the compounders’ injunction.
March 6, 2025
·
3 min read
·
Kate Goodwin
Gyros Protein Technologies Introduces PurePep EasyClean Auto Kit for Automated Parallel Peptide Purification
Gyros Protein Technologies AB announced the launch of its PurePep® EasyClean Auto Kit for the automated parallel purification of peptides, accelerating downstream processes for research, development, and production of simple to complex peptide drugs and therapies.
July 27, 2023
·
2 min read
Series A
Obesity-Focused Antag Debuts With $84M and Backing From Novo Holdings
The Danish startup, whose lead candidate has parallels to Amgen’s MariTide, launches on the heels of Amgen’s Phase II data release for the drug last week.
December 4, 2024
·
2 min read
·
Heather McKenzie
Biotech Beach
Synedgen Completes IND-Enabling Studies for Two Parallel Programs for Lead Asset MIIST305
Synedgen, Inc. announced it has completed IND-enabling studies for its lead candidate, MIIST305.
April 25, 2024
·
4 min read
Business
Parallel Bio Expands Scientific Leadership and Advisors from GSK, MIT, and Stanford
Parallel Bio, a biotech company unlocking the human body’s own power to cure disease, today announced the appointment of Dwight Morrow, a 17-year GSK veteran, as vice president and head of platform.
January 19, 2023
·
3 min read
BioMidwest
World’s first field-installed, clinically approved parallel transmit 7T MRI scanner resides at Auburn University
Auburn University is now home to the world’s first field-installed, clinically approved Terra.X 7 Tesla magnetic resonance imaging scanner — expanding the window for cutting-edge research and public use.
March 26, 2024
·
5 min read
Genetown
Parallel Bio Secures $4.3 Million Seed Round to Accelerate Drug Discovery through Human Immune System in a Dish
Parallel Bio, a biotech company unlocking the human body’s own power to cure disease, today unveiled $4.3 million in seed funding.
December 20, 2022
·
4 min read
BioCapital
Parallel ENT & Allergy Partners Adds Grand Rapids ENT of Michigan to Provide Expanded and Improved Patient Care
Parallel ENT & Allergy Partners has added a second state to its roster of high-quality, innovative ENT and allergy partners with the addition of Grand Rapids ENT.
October 6, 2022
·
3 min read
1 of 1,513
Next
